The average one-year price target for Assertio Holdings (NasdaqCM:ASRT) has been revised to $38.19 / share. This is an ...
Zacks Investment Research on MSN
Is Assertio (ASRT) stock outpacing its medical peers this year?
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Assertio (ASRT) is a stock that can certainly grab the attention ...
Assertio Holdings, Inc. (ASRT) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, ASRT's 50-day simple moving average broke out above ...
What Changed in Assertio’s Fair Value Reset The latest update on Assertio Holdings centres on a very large reset in the fair ...
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Assertio (ASRT) one of those stocks right now? Let's take a ...
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail ...
Assertio Holdings ASRT will report second-quarter 2022 results on Aug 8, before market open. In the second-quarter 2022 results, we expect investors to focus on the sales performance of Assertio’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results